GlassScriptPhysician profile
Jessica Moore
NPI 1972167450
$4,468.20
in general payments reported to CMS, 2019-2025
36 companies · $796 in 2025
The $796 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $744 · 2022: $883 · 2023: $967 · 2024: $1,079 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,841.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $821.35 | 2021-2025 | Barostim Neo System |
| Abiomed | $546.39 | 2023-2025 | Impella |
| Impulse Dynamics (USA) INC. | $426.23 | 2021-2023 | Optimizer |
| Boston Scientific Corporation | $384.69 | 2021-2025 | Watchman Flx, Acuity Steerable, Varithena Administration Pack |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.90 | 2021-2025 | Jardiance |
| Baxter Healthcare | $176.54 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Stryker Corporation | $169.85 | 2025 | Limflow System |
| Abbott Laboratories | $156.49 | 2023 | Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $135.73 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $131.56 | 2021-2025 | Lifevest |
| Edwards Lifesciences Corporation | $126.75 | 2021-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Alnylam Pharmaceuticals INC. | $114.85 | 2021-2025 | Amvuttra |
| Medtronic, INC. | $105.62 | 2022-2025 | Abre, Turbohawk |
| Amgen INC. | $102.00 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $85.31 | 2021-2024 | Verquvo |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $85.28 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $81.43 | 2021-2025 | Wainua, Farxiga |
| Janssen Pharmaceuticals, INC | $75.31 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $72.01 | 2021-2024 | |
| Philips North America LLC | $62.21 | 2023-2024 | (Ck7) Extended Holter, (Ck4) Mcot |
| Glaxosmithkline, LLC. | $53.38 | 2022-2025 | Shingrix, Arexvy |
| Scpharmaceuticals INC. | $45.02 | 2024 | |
| Mckesson Medical-Surgical Minnesota Supply, INC | $34.77 | 2024 | |
| Esperion Therapeutics, INC. | $31.88 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $30.90 | 2021 | |
| Abbvie INC. | $26.32 | 2021 | |
| Sanofi-Aventis U.S. LLC | $23.49 | 2021 | |
| Organogenesis INC. | $22.89 | 2023 | Puraply |
| Genzyme Corporation | $22.36 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $21.00 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $19.82 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $17.87 | 2024 | Arcalyst |
| Atricure, INC. | $14.84 | 2021 | |
| Inspire Medical Systems, INC. | $13.61 | 2023 | Inspire |
| Amarin Pharma, INC. | $13.07 | 2021 | |
| Inogen, INC. | $11.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.